Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa

The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the ac...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet global health Vol. 9; no. 12; pp. e1740 - e1749
Main Authors Martinez, Leonardo, Nicol, Mark P, Wedderburn, Catherine J, Stadler, Attie, Botha, Maresa, Workman, Lesley, le Roux, David M, Zar, Heather J
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2021
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette–Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother–infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2–11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother–infant pairs were followed up for a median of 6·9 years (IQR 6·0–7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2–13·8; p=0·022), 3 months (2·8, 1·4–5·8; p=0·0040), 6 months (3·6, 1·7–7·3; p<0·0001), 12 months (3·2, 1·6–6·4; p=0·0010), and 24 months (4·2, 2·0–8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0–10·6; p=0·048), 6 months (3·9, 1·2–13·0; p=0·027), 12 months (4·4, 1·2–16·3; p=0·027), and 24 months (6·1, 1·3–27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009). Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.
AbstractList The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children.BACKGROUNDThe risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children.In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette-Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs.METHODSIn this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette-Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs.Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother-infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2-11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother-infant pairs were followed up for a median of 6·9 years (IQR 6·0-7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2-13·8; p=0·022), 3 months (2·8, 1·4-5·8; p=0·0040), 6 months (3·6, 1·7-7·3; p<0·0001), 12 months (3·2, 1·6-6·4; p=0·0010), and 24 months (4·2, 2·0-8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0-10·6; p=0·048), 6 months (3·9, 1·2-13·0; p=0·027), 12 months (4·4, 1·2-16·3; p=0·027), and 24 months (6·1, 1·3-27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009).FINDINGSBetween March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother-infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2-11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother-infant pairs were followed up for a median of 6·9 years (IQR 6·0-7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2-13·8; p=0·022), 3 months (2·8, 1·4-5·8; p=0·0040), 6 months (3·6, 1·7-7·3; p<0·0001), 12 months (3·2, 1·6-6·4; p=0·0010), and 24 months (4·2, 2·0-8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0-10·6; p=0·048), 6 months (3·9, 1·2-13·0; p=0·027), 12 months (4·4, 1·2-16·3; p=0·027), and 24 months (6·1, 1·3-27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009).Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life.INTERPRETATIONInfants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life.Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.FUNDINGBill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.
The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette-Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother-infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2-11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother-infant pairs were followed up for a median of 6·9 years (IQR 6·0-7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2-13·8; p=0·022), 3 months (2·8, 1·4-5·8; p=0·0040), 6 months (3·6, 1·7-7·3; p<0·0001), 12 months (3·2, 1·6-6·4; p=0·0010), and 24 months (4·2, 2·0-8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0-10·6; p=0·048), 6 months (3·9, 1·2-13·0; p=0·027), 12 months (4·4, 1·2-16·3; p=0·027), and 24 months (6·1, 1·3-27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; p =0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; p =0·0009). Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.
Background: The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. Methods: In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette–Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Findings: Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother–infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2–11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother–infant pairs were followed up for a median of 6·9 years (IQR 6·0–7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2–13·8; p=0·022), 3 months (2·8, 1·4–5·8; p=0·0040), 6 months (3·6, 1·7–7·3; p<0·0001), 12 months (3·2, 1·6–6·4; p=0·0010), and 24 months (4·2, 2·0–8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0–10·6; p=0·048), 6 months (3·9, 1·2–13·0; p=0·027), 12 months (4·4, 1·2–16·3; p=0·027), and 24 months (6·1, 1·3–27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009). Interpretation: Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Funding: Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.
The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well elucidated. Acquisition of viral infections, such as cytomegalovirus, in early life might modulate the immune system. We aimed to evaluate the acquisition of cytomegalovirus infection in infancy and the development of tuberculosis disease in children. In this prospective, birth cohort study we enrolled pregnant women who were between 20 and 28 weeks of gestation attending antenatal care in Paarl, a periurban setting outside of Cape Town, South Africa. Participants were recruited from two clinics (TC Newman and Mbekweni). Infants were given Bacillus Calmette–Guérin vaccination at birth as per national policy. Nasopharyngeal swabs for cytomegalovirus detection using qPCR were done for infants at birth, age 3 and 6 weeks, and age 3, 6, 12, and 24 months. Children were prospectively followed up for tuberculosis disease until age 9 years using tuberculin skin testing, radiographic examinations, GeneXpert, and sputum testing. Tuberculin skin tests were done at the 6-month visit and then at age 12, 24, 36, 48, and 60 months, and at the time of lower respiratory tract infection. We compared tuberculosis disease incidence after age 1 year or after age 6 months in children with and without cytomegalovirus infection using Cox regression and hazard ratios (HRs) with 95% CIs. Between March 5, 2012, and March 31, 2015, 1225 pregnant women were recruited and enrolled in the birth cohort. 88 (7%) women were excluded because of loss to antenatal follow-up or pregnancy losses. Of 1143 livebirths, 68 (6%) mother–infant pairs were excluded. In total, 963 children were serially tested for cytomegalovirus (7186 cytomegalovirus measurements taken; median six tests per child, IQR 2–11). The prevalence of congenital cytomegalovirus at age younger than 3 weeks was 2% (18 of 816). Cytomegalovirus positivity increased continuously with age from 3% (27 of 825) by age 6 weeks to 21% (183 of 882) by 3 months, 35% (315 of 909) by 6 months, and 42% (390 of 933) by 12 months. Mother–infant pairs were followed up for a median of 6·9 years (IQR 6·0–7·8). The risk of tuberculosis disease in children after age 1 year was higher in those with cytomegalovirus infection by age 6 weeks (adjusted HR 4·1, 95% CI 1·2–13·8; p=0·022), 3 months (2·8, 1·4–5·8; p=0·0040), 6 months (3·6, 1·7–7·3; p<0·0001), 12 months (3·2, 1·6–6·4; p=0·0010), and 24 months (4·2, 2·0–8·8; p<0·0001). The risk of microbiologically confirmed tuberculosis disease was also higher among children acquiring cytomegalovirus infection before age 3 months (adjusted HR 3·2, 95% CI 1·0–10·6; p=0·048), 6 months (3·9, 1·2–13·0; p=0·027), 12 months (4·4, 1·2–16·3; p=0·027), and 24 months (6·1, 1·3–27·9; p=0·020). In children older than 1 year, the risk of tuberculosis disease was consistently greater in those with high cytomegalovirus loads than in those with low cytomegalovirus loads that were acquired before age 3 months (adjusted HR 2·0 vs 3·7; ptrend=0·0020; both groups compared with cytomegalovirus negative reference) and before age 12 months (2·7 vs 3·7; ptrend=0·0009). Infants that acquire cytomegalovirus in the first year of life are at high risk of subsequently developing tuberculosis disease. Efforts to prevent tuberculosis in early childhood in high-burden countries might need to deter or delay acquisition of cytomegalovirus perinatally or in the first months of life. Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.
Author Martinez, Leonardo
Stadler, Attie
Workman, Lesley
Zar, Heather J
Botha, Maresa
Wedderburn, Catherine J
Nicol, Mark P
le Roux, David M
Author_xml – sequence: 1
  givenname: Leonardo
  surname: Martinez
  fullname: Martinez, Leonardo
  organization: Department of Epidemiology, School of Public Health, Boston University, Boston, MA, USA
– sequence: 2
  givenname: Mark P
  surname: Nicol
  fullname: Nicol, Mark P
  organization: Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, WA, Australia
– sequence: 3
  givenname: Catherine J
  surname: Wedderburn
  fullname: Wedderburn, Catherine J
  organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa
– sequence: 4
  givenname: Attie
  surname: Stadler
  fullname: Stadler, Attie
  organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa
– sequence: 5
  givenname: Maresa
  surname: Botha
  fullname: Botha, Maresa
  organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa
– sequence: 6
  givenname: Lesley
  surname: Workman
  fullname: Workman, Lesley
  organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa
– sequence: 7
  givenname: David M
  surname: le Roux
  fullname: le Roux, David M
  organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa
– sequence: 8
  givenname: Heather J
  surname: Zar
  fullname: Zar, Heather J
  email: heather.zar@uct.ac.za
  organization: Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital and South African Medical Research Council Unit on Child and Adolescent Health, Cape Town, South Africa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34798032$$D View this record in MEDLINE/PubMed
BookMark eNqFkt9uFCEUxiemxtbaR9BwWRNXYWBnGC9qmo1_mjTxojXxjpyBww51FrbArNkX8Xmd2a2b9kpCAvn48R1y-F4WRz54LIrXjL5nlFUfbsqSiRmjzc_zkr2lVNB6xp4VJwf56NH-uDhL6Y6Oo2l4WdcvimMu6kZSXp4UfxbbHFa4hD5sXBwSAX0_uOSyC564aVrwekvAG5I7JNGlXyRYkocWox76kFwixiWEhBOvO9ebLgTzkQDpg1-6PBjnoSeti7kjOnQhZpJGdTvxC1gjuQ2__TtyE4YRuLTRaXhVPLfQJzx7WE-LH18-3y6-za6_f71aXF7P9JzzPOMl4xLaWpq2qa0VvBEtomgBEBpt27rijaVcGMaNpbrSYm44ldxQMEKA5afF1d7XBLhT6-hWELcqgFM7IcSlgpid7lFRAXVTVgI1t0LMWyktSmNkrXktKoaj18Xeaz20KzQafY7QPzF9euJdp5Zho2RFm1Ky0eD8wSCG-wFTViuXNPY9eAxDUmVFaSnnDRUjOt-jOoaUItpDGUbVFBG1i4ia_l-VTO0ioqYSbx6_8XDrXyBG4NMewLHrG4dRJe3QazQuos5jW9x_SvwFMefRnw
CitedBy_id crossref_primary_10_3389_fpubh_2024_1359663
crossref_primary_10_1038_s41467_022_34061_7
crossref_primary_10_1016_j_cell_2023_11_002
crossref_primary_10_1093_cid_ciad268
crossref_primary_10_1016_j_actatropica_2023_106987
crossref_primary_10_1016_j_ijid_2022_02_005
crossref_primary_10_1016_S2214_109X_22_00283_2
crossref_primary_10_3389_fimmu_2023_1193058
crossref_primary_10_1093_ofid_ofad487
crossref_primary_10_1016_S2214_109X_21_00466_6
crossref_primary_10_3389_fimmu_2023_1122048
crossref_primary_10_1016_j_jinf_2023_01_002
crossref_primary_10_1093_infdis_jiac179
crossref_primary_10_1093_ofid_ofad449
crossref_primary_10_3389_fpubh_2023_1292762
crossref_primary_10_1016_j_ijtb_2023_11_002
crossref_primary_10_1164_rccm_202208_1543OC
crossref_primary_10_1111_imr_13116
crossref_primary_10_1016_j_jvacx_2023_100267
crossref_primary_10_1016_j_celrep_2022_110896
crossref_primary_10_1016_j_vaccine_2023_06_020
crossref_primary_10_1016_S2213_2600_24_00083_3
Cites_doi 10.1038/nri.2016.38
10.1016/S2055-6640(20)30456-8
10.1371/journal.pone.0222399
10.1172/jci.insight.130090
10.1371/journal.pone.0194186
10.1016/j.humimm.2004.02.014
10.1128/CVI.00385-08
10.1128/CVI.00203-06
10.1093/oxfordjournals.aje.a121593
10.2307/2529620
10.1016/S0140-6736(14)60195-1
10.2105/AJPH.88.1.15
10.1016/0895-4356(95)00510-2
10.1136/bmjopen-2019-033259
10.1093/cid/civ581
10.1086/527418
10.1016/0895-4356(95)00048-8
10.1016/S2214-109X(14)70245-1
10.1164/rccm.201601-0116LE
10.1016/S2352-4642(17)30149-9
10.1016/S0140-6736(20)30166-5
10.1136/thoraxjnl-2014-206242
10.3389/fped.2019.00233
10.1016/S2213-2600(17)30497-6
10.12688/f1000research.14184.2
10.1093/infdis/152.2.243
10.1016/S1473-3099(04)01202-2
10.1542/peds.74.1.121
10.1183/13993003.02245-2018
10.1002/rmv.1862
10.1183/13993003.03028-2020
ContentType Journal Article
Copyright 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021
Copyright_xml – notice: 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
– notice: Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
– notice: 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1016/S2214-109X(21)00407-1
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2214-109X
EndPage e1749
ExternalDocumentID oai_doaj_org_article_04a79264ec3f445b88fe8dd87c37461e
10_1016_S2214_109X_21_00407_1
34798032
S2214109X21004071
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations South Africa
GeographicLocations_xml – name: South Africa
GrantInformation Bill & Melinda Gates Foundation, MRC South Africa, National Research Foundation South Africa, and Wellcome Trust.
GrantInformation_xml – fundername: Wellcome Trust
– fundername: Wellcome Trust
  grantid: 203525/Z/16/Z
– fundername: NHGRI NIH HHS
  grantid: U54 HG009824
– fundername: NIAID NIH HHS
  grantid: U01 AI110466
GroupedDBID .1-
.FO
0R~
0SF
1P~
457
53G
6I.
AACTN
AAEDT
AAEDW
AAFTH
AAIKJ
AALRI
AAXUO
ABMAC
ACGFS
ACHQT
ADBBV
ADEZE
AENEX
AEVXI
AEXQZ
AFCTW
AFRHN
AFTJW
AGHFR
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BCNDV
DIK
EBS
EJD
FDB
GROUPED_DOAJ
HZ~
IPNFZ
IXB
KQ8
M41
M~E
NCXOZ
O9-
OD.
OK1
OO~
RIG
ROL
SSZ
Z5R
AAMRU
ADVLN
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c533t-32138ab78db97ff4394bee4baaea9cfb7639f034d13df0c6c45d3083d0ad44af3
IEDL.DBID IXB
ISSN 2214-109X
IngestDate Sun Sep 29 07:15:54 EDT 2024
Tue Sep 17 21:25:40 EDT 2024
Sun Aug 18 16:32:22 EDT 2024
Thu Sep 26 18:04:16 EDT 2024
Fri Oct 18 09:22:04 EDT 2024
Sat Feb 24 15:48:35 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License This is an open access article under the CC BY license.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c533t-32138ab78db97ff4394bee4baaea9cfb7639f034d13df0c6c45d3083d0ad44af3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S2214109X21004071
PMID 34798032
PQID 2600285904
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_04a79264ec3f445b88fe8dd87c37461e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8609281
proquest_miscellaneous_2600285904
crossref_primary_10_1016_S2214_109X_21_00407_1
pubmed_primary_34798032
elsevier_sciencedirect_doi_10_1016_S2214_109X_21_00407_1
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The Lancet global health
PublicationTitleAlternate Lancet Glob Health
PublicationYear 2021
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Moss, Khan (bib10) 2004; 65
Graham, Cuevas, Jean-Philippe (bib22) 2015; 61
Dupont, Reeves (bib31) 2016; 26
Farhat, Greenaway, Pai, Menzies (bib36) 2006; 10
Martinez, Cords, Horsburgh, Andrews (bib3) 2020; 395
Fang, Fan, Yang (bib28) 2009; 16
Klenerman, Oxenius (bib11) 2016; 16
Cobelens, Nagelkerke, Fletcher (bib8) 2018; 7
Fletcher, Snowden, Landry (bib12) 2016; 7
Rockhill, Newman, Weinberg (bib26) 1998; 88
Gandhi, Khanna (bib29) 2004; 4
Wilkinson, Oni, Gideon, Goliath, Wilkinson, Riou (bib13) 2016; 193
Zar, Barnett, Myer, Stein, Nicol (bib16) 2015; 70
Gupta, Rosenberg, Eriksen (bib33) 2019; 54
Breslow (bib25) 1974; 30
Miles, Sande, Kaye (bib32) 2008; 197
Whittaker, López-Varela, Broderick, Seddon (bib35) 2019; 7
Pass, Hutto, Reynolds, Polhill (bib30) 1984; 74
Peduzzi, Concato, Feinstein, Holford (bib24) 1995; 48
Martinez, le Roux, Barnett, Stadler, Nicol, Zar (bib17) 2018; 2
Jenkins, Tolman, Yuen (bib2) 2014; 383
Madrid, Varo, Maculuve (bib20) 2018; 13
Kampmann, Whittaker (bib7) 2016
Concato, Peduzzi, Holford, Feinstein (bib23) 1995; 48
Zar, Pellowski, Cohen (bib18) 2019; 14
Martinez, Shen, Handel (bib5) 2018; 6
Mandalakas, Hesseling, Kay (bib6) 2021; 57
(bib21) 2014
Stockdale, Nash, Farmer (bib34) 2020; 221
Pass (bib9) 1985; 152
Müller, Tanner, Matsumiya (bib15) 2019; 4
Seale, MacIntyre, Gidding, Backhouse, Dwyer, Gilbert (bib27) 2006; 13
Bates, Brantsaeter (bib14) 2016; 2
Pellowski, Wedderburn, Stadler (bib19) 2019; 9
Dodd, Gardiner, Coghlan, Seddon (bib1) 2014; 2
Comstock, Livesay, Woolpert (bib4) 1974; 99
34798013 - Lancet Glob Health. 2021 Dec;9(12):e1636-e1637
34800373 - Lancet Glob Health. 2021 Nov 17
Müller (10.1016/S2214-109X(21)00407-1_bib15) 2019; 4
Pellowski (10.1016/S2214-109X(21)00407-1_bib19) 2019; 9
Breslow (10.1016/S2214-109X(21)00407-1_bib25) 1974; 30
Dupont (10.1016/S2214-109X(21)00407-1_bib31) 2016; 26
Fletcher (10.1016/S2214-109X(21)00407-1_bib12) 2016; 7
Moss (10.1016/S2214-109X(21)00407-1_bib10) 2004; 65
Wilkinson (10.1016/S2214-109X(21)00407-1_bib13) 2016; 193
Seale (10.1016/S2214-109X(21)00407-1_bib27) 2006; 13
Fang (10.1016/S2214-109X(21)00407-1_bib28) 2009; 16
Zar (10.1016/S2214-109X(21)00407-1_bib16) 2015; 70
Miles (10.1016/S2214-109X(21)00407-1_bib32) 2008; 197
Cobelens (10.1016/S2214-109X(21)00407-1_bib8) 2018; 7
Madrid (10.1016/S2214-109X(21)00407-1_bib20) 2018; 13
Martinez (10.1016/S2214-109X(21)00407-1_bib17) 2018; 2
Kampmann (10.1016/S2214-109X(21)00407-1_bib7) 2016
Pass (10.1016/S2214-109X(21)00407-1_bib30) 1984; 74
Zar (10.1016/S2214-109X(21)00407-1_bib18) 2019; 14
Rockhill (10.1016/S2214-109X(21)00407-1_bib26) 1998; 88
Martinez (10.1016/S2214-109X(21)00407-1_bib3) 2020; 395
Mandalakas (10.1016/S2214-109X(21)00407-1_bib6) 2021; 57
Concato (10.1016/S2214-109X(21)00407-1_bib23) 1995; 48
Martinez (10.1016/S2214-109X(21)00407-1_bib5) 2018; 6
Jenkins (10.1016/S2214-109X(21)00407-1_bib2) 2014; 383
Gandhi (10.1016/S2214-109X(21)00407-1_bib29) 2004; 4
Pass (10.1016/S2214-109X(21)00407-1_bib9) 1985; 152
Bates (10.1016/S2214-109X(21)00407-1_bib14) 2016; 2
Farhat (10.1016/S2214-109X(21)00407-1_bib36) 2006; 10
Comstock (10.1016/S2214-109X(21)00407-1_bib4) 1974; 99
Dodd (10.1016/S2214-109X(21)00407-1_bib1) 2014; 2
Whittaker (10.1016/S2214-109X(21)00407-1_bib35) 2019; 7
Klenerman (10.1016/S2214-109X(21)00407-1_bib11) 2016; 16
Stockdale (10.1016/S2214-109X(21)00407-1_bib34) 2020; 221
Gupta (10.1016/S2214-109X(21)00407-1_bib33) 2019; 54
Graham (10.1016/S2214-109X(21)00407-1_bib22) 2015; 61
Peduzzi (10.1016/S2214-109X(21)00407-1_bib24) 1995; 48
References_xml – volume: 7
  start-page: 233
  year: 2019
  ident: bib35
  article-title: Examining the complex relationship between tuberculosis and other infectious diseases in children
  publication-title: Front Pediatr
  contributor:
    fullname: Seddon
– start-page: 31
  year: 2016
  end-page: 45
  ident: bib7
  article-title: Immunology of tuberculosis in children
  publication-title: Handbook of child and adolescent tuberculosis
  contributor:
    fullname: Whittaker
– volume: 193
  start-page: 1307
  year: 2016
  end-page: 1310
  ident: bib13
  article-title: Activation profile of
  publication-title: Am J Respir Crit Care Med
  contributor:
    fullname: Riou
– volume: 16
  start-page: 1700
  year: 2009
  end-page: 1703
  ident: bib28
  article-title: Incidence of cytomegalovirus infection in Shanghai, China
  publication-title: Clin Vaccine Immunol
  contributor:
    fullname: Yang
– volume: 48
  start-page: 1503
  year: 1995
  end-page: 1510
  ident: bib24
  article-title: Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates
  publication-title: J Clin Epidemiol
  contributor:
    fullname: Holford
– volume: 7
  start-page: 280
  year: 2018
  ident: bib8
  article-title: The convergent epidemiology of tuberculosis and human cytomegalovirus infection
  publication-title: F1000 Res
  contributor:
    fullname: Fletcher
– volume: 10
  start-page: 1192
  year: 2006
  end-page: 1204
  ident: bib36
  article-title: False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?
  publication-title: Int J Tuberc Lung Dis
  contributor:
    fullname: Menzies
– volume: 2
  start-page: e453
  year: 2014
  end-page: e459
  ident: bib1
  article-title: Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study
  publication-title: Lancet Glob Health
  contributor:
    fullname: Seddon
– year: 2014
  ident: bib21
  article-title: Guidance for national tuberculosis programmes on the management of tuberculosis in children
– volume: 65
  start-page: 456
  year: 2004
  end-page: 464
  ident: bib10
  article-title: CD8(+) T-cell immunity to cytomegalovirus
  publication-title: Hum Immunol
  contributor:
    fullname: Khan
– volume: 30
  start-page: 89
  year: 1974
  end-page: 99
  ident: bib25
  article-title: Covariance analysis of censored survival data
  publication-title: Biometrics
  contributor:
    fullname: Breslow
– volume: 7
  year: 2016
  ident: bib12
  article-title: T-cell activation is an immune correlate of risk in BCG vaccinated infants
  publication-title: Nat Commun
  contributor:
    fullname: Landry
– volume: 61
  start-page: S179
  year: 2015
  end-page: S187
  ident: bib22
  article-title: Clinical case definitions for classification of intrathoracic tuberculosis in children: an update
  publication-title: Clin Infect Dis
  contributor:
    fullname: Jean-Philippe
– volume: 221
  start-page: 1127
  year: 2020
  end-page: 1134
  ident: bib34
  article-title: Cytomegalovirus antibody responses associated with increased risk of tuberculosis disease in Ugandan adults
  publication-title: J Infect Dis
  contributor:
    fullname: Farmer
– volume: 57
  year: 2021
  ident: bib6
  article-title: Tuberculosis prevention in children: a prospective community-based study in South Africa
  publication-title: Eur Respir J
  contributor:
    fullname: Kay
– volume: 70
  start-page: 592
  year: 2015
  end-page: 594
  ident: bib16
  article-title: Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study
  publication-title: Thorax
  contributor:
    fullname: Nicol
– volume: 383
  start-page: 1572
  year: 2014
  end-page: 1579
  ident: bib2
  article-title: Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates
  publication-title: Lancet
  contributor:
    fullname: Yuen
– volume: 6
  start-page: 276
  year: 2018
  end-page: 286
  ident: bib5
  article-title: Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda
  publication-title: Lancet Respir Med
  contributor:
    fullname: Handel
– volume: 4
  start-page: 725
  year: 2004
  end-page: 738
  ident: bib29
  article-title: Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
  publication-title: Lancet Infect Dis
  contributor:
    fullname: Khanna
– volume: 48
  start-page: 1495
  year: 1995
  end-page: 1501
  ident: bib23
  article-title: Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy
  publication-title: J Clin Epidemiol
  contributor:
    fullname: Feinstein
– volume: 152
  start-page: 243
  year: 1985
  end-page: 248
  ident: bib9
  article-title: Epidemiology and transmission of cytomegalovirus
  publication-title: J Infect Dis
  contributor:
    fullname: Pass
– volume: 99
  start-page: 131
  year: 1974
  end-page: 138
  ident: bib4
  article-title: The prognosis of a positive tuberculin reaction in childhood and adolescence
  publication-title: Am J Epidemiol
  contributor:
    fullname: Woolpert
– volume: 14
  year: 2019
  ident: bib18
  article-title: Maternal health and birth outcomes in a South African birth cohort study
  publication-title: PLoS One
  contributor:
    fullname: Cohen
– volume: 13
  start-page: 1181
  year: 2006
  end-page: 1184
  ident: bib27
  article-title: National serosurvey of cytomegalovirus in Australia
  publication-title: Clin Vaccine Immunol
  contributor:
    fullname: Gilbert
– volume: 197
  start-page: 658
  year: 2008
  end-page: 662
  ident: bib32
  article-title: CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study
  publication-title: J Infect Dis
  contributor:
    fullname: Kaye
– volume: 2
  start-page: 46
  year: 2018
  end-page: 55
  ident: bib17
  article-title: Tuberculin skin test conversion and primary progressive tuberculosis disease in the first 5 years of life: a birth cohort study from Cape Town, South Africa
  publication-title: Lancet Child Adolesc Health
  contributor:
    fullname: Zar
– volume: 74
  start-page: 121
  year: 1984
  end-page: 126
  ident: bib30
  article-title: Increased frequency of cytomegalovirus infection in children in group day care
  publication-title: Pediatrics
  contributor:
    fullname: Polhill
– volume: 88
  start-page: 15
  year: 1998
  end-page: 19
  ident: bib26
  article-title: Use and misuse of population attributable fractions
  publication-title: Am J Public Health
  contributor:
    fullname: Weinberg
– volume: 26
  start-page: 75
  year: 2016
  end-page: 89
  ident: bib31
  article-title: Cytomegalovirus latency and reactivation: recent insights into an age old problem
  publication-title: Rev Med Virol
  contributor:
    fullname: Reeves
– volume: 4
  year: 2019
  ident: bib15
  article-title: Cytomegalovirus infection is a risk factor for tuberculosis disease in infants
  publication-title: JCI Insight
  contributor:
    fullname: Matsumiya
– volume: 2
  start-page: 136
  year: 2016
  end-page: 142
  ident: bib14
  article-title: Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
  publication-title: J Virus Erad
  contributor:
    fullname: Brantsaeter
– volume: 54
  year: 2019
  ident: bib33
  article-title: Tuberculosis following renal transplantation in England, Wales and Northern Ireland: a national registry-based cohort study
  publication-title: Eur Respir J
  contributor:
    fullname: Eriksen
– volume: 16
  start-page: 367
  year: 2016
  end-page: 377
  ident: bib11
  article-title: T cell responses to cytomegalovirus
  publication-title: Nat Rev Immunol
  contributor:
    fullname: Oxenius
– volume: 9
  year: 2019
  ident: bib19
  article-title: Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape
  publication-title: BMJ Open
  contributor:
    fullname: Stadler
– volume: 13
  year: 2018
  ident: bib20
  article-title: Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: a cross-sectional survey
  publication-title: PLoS One
  contributor:
    fullname: Maculuve
– volume: 395
  start-page: 973
  year: 2020
  end-page: 984
  ident: bib3
  article-title: The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
  publication-title: Lancet
  contributor:
    fullname: Andrews
– volume: 16
  start-page: 367
  year: 2016
  ident: 10.1016/S2214-109X(21)00407-1_bib11
  article-title: T cell responses to cytomegalovirus
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri.2016.38
  contributor:
    fullname: Klenerman
– volume: 2
  start-page: 136
  year: 2016
  ident: 10.1016/S2214-109X(21)00407-1_bib14
  article-title: Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
  publication-title: J Virus Erad
  doi: 10.1016/S2055-6640(20)30456-8
  contributor:
    fullname: Bates
– volume: 221
  start-page: 1127
  year: 2020
  ident: 10.1016/S2214-109X(21)00407-1_bib34
  article-title: Cytomegalovirus antibody responses associated with increased risk of tuberculosis disease in Ugandan adults
  publication-title: J Infect Dis
  contributor:
    fullname: Stockdale
– volume: 14
  year: 2019
  ident: 10.1016/S2214-109X(21)00407-1_bib18
  article-title: Maternal health and birth outcomes in a South African birth cohort study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0222399
  contributor:
    fullname: Zar
– volume: 4
  year: 2019
  ident: 10.1016/S2214-109X(21)00407-1_bib15
  article-title: Cytomegalovirus infection is a risk factor for tuberculosis disease in infants
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.130090
  contributor:
    fullname: Müller
– volume: 13
  year: 2018
  ident: 10.1016/S2214-109X(21)00407-1_bib20
  article-title: Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: a cross-sectional survey
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0194186
  contributor:
    fullname: Madrid
– volume: 65
  start-page: 456
  year: 2004
  ident: 10.1016/S2214-109X(21)00407-1_bib10
  article-title: CD8(+) T-cell immunity to cytomegalovirus
  publication-title: Hum Immunol
  doi: 10.1016/j.humimm.2004.02.014
  contributor:
    fullname: Moss
– volume: 16
  start-page: 1700
  year: 2009
  ident: 10.1016/S2214-109X(21)00407-1_bib28
  article-title: Incidence of cytomegalovirus infection in Shanghai, China
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00385-08
  contributor:
    fullname: Fang
– volume: 13
  start-page: 1181
  year: 2006
  ident: 10.1016/S2214-109X(21)00407-1_bib27
  article-title: National serosurvey of cytomegalovirus in Australia
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00203-06
  contributor:
    fullname: Seale
– volume: 99
  start-page: 131
  year: 1974
  ident: 10.1016/S2214-109X(21)00407-1_bib4
  article-title: The prognosis of a positive tuberculin reaction in childhood and adolescence
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a121593
  contributor:
    fullname: Comstock
– volume: 30
  start-page: 89
  year: 1974
  ident: 10.1016/S2214-109X(21)00407-1_bib25
  article-title: Covariance analysis of censored survival data
  publication-title: Biometrics
  doi: 10.2307/2529620
  contributor:
    fullname: Breslow
– volume: 383
  start-page: 1572
  year: 2014
  ident: 10.1016/S2214-109X(21)00407-1_bib2
  article-title: Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)60195-1
  contributor:
    fullname: Jenkins
– volume: 88
  start-page: 15
  year: 1998
  ident: 10.1016/S2214-109X(21)00407-1_bib26
  article-title: Use and misuse of population attributable fractions
  publication-title: Am J Public Health
  doi: 10.2105/AJPH.88.1.15
  contributor:
    fullname: Rockhill
– volume: 48
  start-page: 1495
  year: 1995
  ident: 10.1016/S2214-109X(21)00407-1_bib23
  article-title: Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy
  publication-title: J Clin Epidemiol
  doi: 10.1016/0895-4356(95)00510-2
  contributor:
    fullname: Concato
– volume: 9
  year: 2019
  ident: 10.1016/S2214-109X(21)00407-1_bib19
  article-title: Implementation of prevention of mother-to-child transmission (PMTCT) in South Africa: outcomes from a population-based birth cohort study in Paarl, Western Cape
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2019-033259
  contributor:
    fullname: Pellowski
– volume: 10
  start-page: 1192
  year: 2006
  ident: 10.1016/S2214-109X(21)00407-1_bib36
  article-title: False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?
  publication-title: Int J Tuberc Lung Dis
  contributor:
    fullname: Farhat
– volume: 61
  start-page: S179
  issue: suppl 3
  year: 2015
  ident: 10.1016/S2214-109X(21)00407-1_bib22
  article-title: Clinical case definitions for classification of intrathoracic tuberculosis in children: an update
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/civ581
  contributor:
    fullname: Graham
– volume: 197
  start-page: 658
  year: 2008
  ident: 10.1016/S2214-109X(21)00407-1_bib32
  article-title: CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study
  publication-title: J Infect Dis
  doi: 10.1086/527418
  contributor:
    fullname: Miles
– volume: 48
  start-page: 1503
  year: 1995
  ident: 10.1016/S2214-109X(21)00407-1_bib24
  article-title: Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates
  publication-title: J Clin Epidemiol
  doi: 10.1016/0895-4356(95)00048-8
  contributor:
    fullname: Peduzzi
– volume: 2
  start-page: e453
  year: 2014
  ident: 10.1016/S2214-109X(21)00407-1_bib1
  article-title: Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study
  publication-title: Lancet Glob Health
  doi: 10.1016/S2214-109X(14)70245-1
  contributor:
    fullname: Dodd
– volume: 193
  start-page: 1307
  year: 2016
  ident: 10.1016/S2214-109X(21)00407-1_bib13
  article-title: Activation profile of Mycobacterium tuberculosis-specific CD4(1) T cells reflects disease activity irrespective of HIV status
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201601-0116LE
  contributor:
    fullname: Wilkinson
– volume: 2
  start-page: 46
  year: 2018
  ident: 10.1016/S2214-109X(21)00407-1_bib17
  article-title: Tuberculin skin test conversion and primary progressive tuberculosis disease in the first 5 years of life: a birth cohort study from Cape Town, South Africa
  publication-title: Lancet Child Adolesc Health
  doi: 10.1016/S2352-4642(17)30149-9
  contributor:
    fullname: Martinez
– volume: 395
  start-page: 973
  year: 2020
  ident: 10.1016/S2214-109X(21)00407-1_bib3
  article-title: The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30166-5
  contributor:
    fullname: Martinez
– volume: 70
  start-page: 592
  year: 2015
  ident: 10.1016/S2214-109X(21)00407-1_bib16
  article-title: Investigating the early-life determinants of illness in Africa: the Drakenstein Child Health Study
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2014-206242
  contributor:
    fullname: Zar
– volume: 7
  start-page: 233
  year: 2019
  ident: 10.1016/S2214-109X(21)00407-1_bib35
  article-title: Examining the complex relationship between tuberculosis and other infectious diseases in children
  publication-title: Front Pediatr
  doi: 10.3389/fped.2019.00233
  contributor:
    fullname: Whittaker
– volume: 6
  start-page: 276
  year: 2018
  ident: 10.1016/S2214-109X(21)00407-1_bib5
  article-title: Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(17)30497-6
  contributor:
    fullname: Martinez
– volume: 7
  start-page: 280
  year: 2018
  ident: 10.1016/S2214-109X(21)00407-1_bib8
  article-title: The convergent epidemiology of tuberculosis and human cytomegalovirus infection
  publication-title: F1000 Res
  doi: 10.12688/f1000research.14184.2
  contributor:
    fullname: Cobelens
– volume: 152
  start-page: 243
  year: 1985
  ident: 10.1016/S2214-109X(21)00407-1_bib9
  article-title: Epidemiology and transmission of cytomegalovirus
  publication-title: J Infect Dis
  doi: 10.1093/infdis/152.2.243
  contributor:
    fullname: Pass
– volume: 4
  start-page: 725
  year: 2004
  ident: 10.1016/S2214-109X(21)00407-1_bib29
  article-title: Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(04)01202-2
  contributor:
    fullname: Gandhi
– volume: 74
  start-page: 121
  year: 1984
  ident: 10.1016/S2214-109X(21)00407-1_bib30
  article-title: Increased frequency of cytomegalovirus infection in children in group day care
  publication-title: Pediatrics
  doi: 10.1542/peds.74.1.121
  contributor:
    fullname: Pass
– volume: 54
  year: 2019
  ident: 10.1016/S2214-109X(21)00407-1_bib33
  article-title: Tuberculosis following renal transplantation in England, Wales and Northern Ireland: a national registry-based cohort study
  publication-title: Eur Respir J
  doi: 10.1183/13993003.02245-2018
  contributor:
    fullname: Gupta
– volume: 26
  start-page: 75
  year: 2016
  ident: 10.1016/S2214-109X(21)00407-1_bib31
  article-title: Cytomegalovirus latency and reactivation: recent insights into an age old problem
  publication-title: Rev Med Virol
  doi: 10.1002/rmv.1862
  contributor:
    fullname: Dupont
– volume: 57
  year: 2021
  ident: 10.1016/S2214-109X(21)00407-1_bib6
  article-title: Tuberculosis prevention in children: a prospective community-based study in South Africa
  publication-title: Eur Respir J
  doi: 10.1183/13993003.03028-2020
  contributor:
    fullname: Mandalakas
– start-page: 31
  year: 2016
  ident: 10.1016/S2214-109X(21)00407-1_bib7
  article-title: Immunology of tuberculosis in children
  contributor:
    fullname: Kampmann
– volume: 7
  year: 2016
  ident: 10.1016/S2214-109X(21)00407-1_bib12
  article-title: T-cell activation is an immune correlate of risk in BCG vaccinated infants
  publication-title: Nat Commun
  contributor:
    fullname: Fletcher
SSID ssj0000993277
Score 2.4472432
Snippet The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are not well...
Background: The risk of tuberculosis disease after recent exposure is greatest before age 5 years; however, the mechanisms explaining this increased risk are...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e1740
SubjectTerms Child
Child, Preschool
Cohort Studies
Cytomegalovirus Infections - complications
Cytomegalovirus Infections - diagnosis
Female
Humans
Infant
Infant, Newborn
Longitudinal Studies
Male
Prospective Studies
Real-Time Polymerase Chain Reaction
South Africa - epidemiology
Tuberculosis, Pulmonary - diagnosis
Tuberculosis, Pulmonary - etiology
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT0gI8WZ5yUgcQCI0fmzscIMVVYUEF6i0N8tPNahNSjap1D_C78VjZ5cNHHpBinJILCfOjGe-2DPzIfSKAUzlghaOcVNwJ6IdtPFURefqJbPUJ7KJL1-r4xP-eb1c71F9QUxYLg-cP9xhybWoo9f2lgXOl0bK4KVzUlgmeEV8sr5kufcz9SPjHkYT7SKlhEdbU6__pO8cfttdfE3JG9BjUZCZY0r1-2f-6V_8-XcY5Z5fOrqDbk-AEn_IA7mLbvj2HrqVV-NwTjK6j36trobu3Edv0F02_bjB2v4cmxyuhRs4AlhZrFuHIyLEEHCOu4CH0fjejmfdptngaS8H2tttQeT3WOOzDjiPRgf8Wtg0_XCKgXa3H3CqXQvtV_rCY1jIfosTZx_O9EQP0MnRp--r42JiZChshIVDwShhUhshnalFCJBVa7znRmuvaxtMNFZ1KBl3hLlQ2srypWMR5LlSO851YA_RQdu1_jHCNIjKcC60IbGD0tS2qnxteF3RUlsuF-jdVhzqIhfeULuINJAf7J2vFSUqyU-RBfoIQts1hrrZ6ULUJjVpk7pOmxZIbkWuJgiSoUXsqrnu-S-3KqLiFIV9F936btwo4ACAOoElX6BHWWV2bwmJvLJkdIHETJlmw5jfaZvTVAZcVmVNJXnyP8b9FN2kEKyT4nSeoYOhH_3ziLYG8yJNrN9iuCWR
  priority: 102
  providerName: Directory of Open Access Journals
Title Cytomegalovirus acquisition in infancy and the risk of tuberculosis disease in childhood: a longitudinal birth cohort study in Cape Town, South Africa
URI https://dx.doi.org/10.1016/S2214-109X(21)00407-1
https://www.ncbi.nlm.nih.gov/pubmed/34798032
https://www.proquest.com/docview/2600285904/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC8609281
https://doaj.org/article/04a79264ec3f445b88fe8dd87c37461e
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9UwEA7LPgki3j1elgg-KFhPmuQ0qW_uwWUR9EUX-hZydQtre-xpBf-Iv9dM2h6tPghC6UOapmlnOjMkM9-H0DMGYSoXNHOMm4w7Ee2gjaciOlcvmaU-kU28_1CcX_B31aY6Qtu5FgbSKifbP9r0ZK2nlvX0Nde7ul5_pBRyFMuKAugZSXXkgO0JRXzV6WGdJUZAjCYCRuifwQ2_CnnGQVLjc5q_SONk-cJFJST_haf6OxL9M6HyNw91dhPdmEJL_Gac_S105Jvb6Pq4LofHcqM76Mf2e99-8dEvtN_qbthjbb8O9Zi4hWs4AthbrBuHY2yIIfUctwH3g_GdHa7afb3H064O9LczNPJrrPFVC-xHgwOmLWzqrr_EQMDb9Tih2EL_rd55DEvaL3Fi78MjUdFddHH29tP2PJu4GTIbA8Q-YzRnUhshnSlFCFBfa7znRmuvSxtMNFtlIIy7nLlAbGH5xrEY7jmiHec6sHvouGkb_wBhGkRhOBfa5HEAYkpbFL40vCwo0ZbLFXo1i0PtRggOdchNA_nBLnqlaK6S_FS-QqcgtENnQNBODW33WU0qpAjXoozRoLcscL4xUgYvnZPCMsGL3K-QnEWuFgoZh6r_9fyns4qo-LPCDoxufDvsFbABAGIg4St0f1SZwyyhpFcSRldILJRp8RrLK019mQDBZUFKKvOH_z_lR-gahWSdlKfzGB333eCfxGirNydpleIk_VQ_ASZ6JuA
link.rule.ids 230,315,786,790,870,891,2115,3525,27955,27956,45907
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcgAJId6Ep5E4gETYxPYmDje6olqg7YVWys3ys41UkiWbIPFH-L14nGQhcEBCWu3BsR3vzmTmiz0zH0IvKMBUlpPYUKZiZnJvB7X_yrxztZxqYgPZxPFJtj5jH8tluYdWUy4MhFWOtn-w6cFajy2L8d9cbKpq8ZkQiFEsSgJFzxLII7_Clv5dD7L4yoPdRouHQJQEBkYYEMOIX5k8wyyh8SVJX4WJ4nTmo0Ip_5mr-huK_hlR-ZuLOryJbozYEr8bln8L7dn6Nro-bMzhId_oDvqx-t41X6x3DM23qu23WOqvfTVEbuEKPg4MLpa1wR4cYog9x43DXa9sq_vLZltt8XisA_31VBv5LZb4sgH6o94A1RZWVdtdYGDgbTscythC_5XcWAx72q9xoO_DA1PRXXR2-P50tY5HcoZYe4TYxZSklEuVc6OK3DlIsFXWMiWllYV2ytutwiWUmZQal-hMs6WhHu-ZRBrGpKP30H7d1PYBwsTlmWIslyr1EySq0FlmC8WKjCRSMx6hN5M4xGaowSF2wWkgPzhGLwVJRZCfSCN0AELbdYYS2qGhac_FqEMiYTIvPBy0mjrGlopzZ7kxPNc0Z1lqI8QnkYuZRvqpqn_d__mkIsI_rXAEI2vb9FsBdABQMjBhEbo_qMxulZDTyxNKIpTPlGn2M-ZX6uoiVATnWVIQnj78_yU_Q1fXp8dH4ujDyadH6BqByJ0QtPMY7Xdtb5946NWpp-HR-gkTpSkQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cytomegalovirus+acquisition+in+infancy+and+the+risk+of+tuberculosis+disease+in+childhood%3A+a+longitudinal+birth+cohort+study+in+Cape+Town%2C+South+Africa&rft.jtitle=The+Lancet+global+health&rft.au=Martinez%2C+Leonardo&rft.au=Nicol%2C+Mark+P&rft.au=Wedderburn%2C+Catherine+J&rft.au=Stadler%2C+Attie&rft.date=2021-12-01&rft.issn=2214-109X&rft.eissn=2214-109X&rft.volume=9&rft.issue=12&rft.spage=e1740&rft_id=info:doi/10.1016%2FS2214-109X%2821%2900407-1&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-109X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-109X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-109X&client=summon